🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesDo the heart benefits go away if I stop taking it? — looking for input Page 5

Do the heart benefits go away if I stop taking it? — looking for input

DeniseRN_TPA Sat, Oct 19, 2024 at 12:02 AM 45 replies 2,308 viewsPage 5 of 9
MikeFit_NJ
Senior Member
1,567
6,543
Apr 2024
New Jersey
Nov 15, 2024 at 9:18 AM#21
emily_PDX said:
I want to bring up the cardiovascular angle on cardiovascular risk.

Second this. I had assumed I was the exception until I read this.

9 7LeilaHI, marcus_mpls, DeniseRN_TPA and 6 others
Reply Quote Save Share Report
RunnerRach
Member
467
2,123
Aug 2024
Boston, MA
Nov 24, 2024 at 8:19 AM#22
emily_PDX said:
I want to bring up the cardiovascular angle on cardiovascular risk.

Lp(a) and cardiovascular risk: a nuance that matters. Unlike most lipid markers, Lp(a) is 90%+ genetically determined and doesn't really change with weight loss or GLP-1 therapy.

My Lp(a) has remained at 80 nmol/L across all time points. If yours is elevated (>50 nmol/L), you need additional risk mitigation strategies regardless of your GLP-1 response. Don't assume your medication is covering all cardiovascular risk factors.

10 8MikeKY_noInsulin, Dr.RaviCardio, jennifer_SEA and 7 others
Reply Quote Save Share Report
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
Dec 3, 2024 at 7:15 AM#23
emily_PDX said:
I want to bring up the cardiovascular angle on cardiovascular risk.

Vitamin deficiency cascade with cardiovascular risk: after 6+ months of reduced food intake, I developed a subtle but important pattern: low B12 → elevated homocysteine → increased cardiovascular risk marker.

The connection: B12 is a cofactor for homocysteine metabolism. Without adequate B12, homocysteine accumulates. This is ironic — taking a CV-protective medication while developing a CV risk factor from reduced nutrition.

Solution: comprehensive vitamin supplementation and regular lab monitoring. Don't let the medication's benefits be undermined by nutritional deficiencies.

Last edited: Dec 3, 2024 at 1:15 PM
11 9mona_PHX, andrew_nyc, Dr.EndoEP and 8 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
InsuranceTom
Senior Member
1,345
7,890
Mar 2024
Connecticut
Dec 12, 2024 at 6:05 AM#24

A narrower follow-up, since the general answer is now clear:

What did you change at the same time, and can you separate the two now?

12 10matt_MKE, Dr.ReproEndo, lucas_SP_BR and 9 others
Reply Quote Save Share Report
MikeKY_noInsulin
Member
267
1,234
Oct 2024
Louisville, KY
Dec 21, 2024 at 4:50 AM#25
quinn_sf said:
Vitamin deficiency cascade with cardiovascular risk: after 6+ months of reduced food intake, I developed a subtle but important pattern: low B12 →…
quinn_sf said:
...we're creating a generation dependent on cardiovascular risk...

I understand the concern, but consider this analogy: are we "creating a generation dependent on" blood pressure medication? Cholesterol medication? Thyroid medication?

Obesity is a chronic disease with biological drivers. Treating it with medication is no different from treating any other chronic condition. The "dependency" framing implies weakness or moral failure — neither of which is accurate.

If ongoing medication is what keeps someone healthy, that's successful treatment, not dependency.

13 11bbq_ray_KC, oliver_london, tane_welly and 10 others
Reply Quote Save Share Report
1345679

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register